Drug Trial Radar · NCT02386592
Prevention of Nosocomial Bacteremia Among Zambian Neonates
Last checked: Nov 19, 2026Latest source record: Jul 31, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
9,410
Actual
Start
Sep 1, 2015
Primary completion
Apr 15, 2017
Study completion Jul 2017
Sponsor
- Lead sponsor
- Boston UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University Teaching Hospital, Lusaka, Zambia; Zambia Center for Applied Health Research and Development; Children's Hospital of Philadelphia
- First posted
- Mar 12, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 1 hour, up to 28 days
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to estimate the burden of disease, identify risk factors associated with nosocomial bacteremia among neonates and assess the efficacy of low-cost measures targeted to known and suspected nosocomial BSI (bloodstream) risk factors, the investigators propose to study the impact of a novel package of infection control interventions on nosocomial bacteremia and mortality among neonates at a tertiary care center in sub-Saharan Africa.
Conditions
- Neonatal Sepsis
- Neonatal Mortality
Interventions
Chlorhexidine gluconate (CHG)Drug
All enrolled neonates admitted to the NICU during the implementation and intervention periods will undergo CHG bathing (sparing head and face) at the time of admission at and thereafter once weekly.
Hand hygiene (HH)Behavioral
Alcohol hand rub will be produced in the hospital pharmacy and will be readily available in the NICU (via wall-mounted dispensers) throughout the intervention period. Hand hygiene among NICU physicians and nurses will actively be promoted through the intervention period.
Infection control trainingBehavioral
All NICU healthcare workers will receive infection prevention training which will involve structure training on HH, universal precautions, neonatal skin antisepsis and peripheral IV placement and line care.
Infection control reminders via SMS textOther
Infection control practice reminders will be sent to NICU healthcare workers on a daily basis via SMS messages.
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause neonatal mortality in hospitalized neonatesTime frame: 18 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Teaching Hospital
Lusaka, Zambia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.